chrX-91878301-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_032968.5(PCDH11X):c.2061G>A(p.Pro687=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0017 in 1,208,256 control chromosomes in the GnomAD database, including 14 homozygotes. There are 576 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0074 ( 5 hom., 220 hem., cov: 20)
Exomes 𝑓: 0.0011 ( 9 hom. 356 hem. )
Consequence
PCDH11X
NM_032968.5 synonymous
NM_032968.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.458
Genes affected
PCDH11X (HGNC:8656): (protocadherin 11 X-linked) This gene belongs to the protocadherin gene family, a subfamily of the cadherin superfamily. The encoded protein consists of an extracellular domain containing 7 cadherin repeats, a transmembrane domain and a cytoplasmic tail that differs from those of the classical cadherins. The gene is located in a major X/Y block of homology and its Y homolog, despite divergence leading to coding region changes, is the most closely related cadherin family member. The protein is thought to play a fundamental role in cell-cell recognition essential for the segmental development and function of the central nervous system. Disruption of this gene may be associated with developmental dyslexia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant X-91878301-G-A is Benign according to our data. Variant chrX-91878301-G-A is described in ClinVar as [Benign]. Clinvar id is 787161.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.458 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00744 (820/110167) while in subpopulation AFR AF= 0.0231 (698/30272). AF 95% confidence interval is 0.0216. There are 5 homozygotes in gnomad4. There are 220 alleles in male gnomad4 subpopulation. Median coverage is 20. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PCDH11X | NM_032968.5 | c.2061G>A | p.Pro687= | synonymous_variant | 6/11 | ENST00000682573.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PCDH11X | ENST00000682573.1 | c.2061G>A | p.Pro687= | synonymous_variant | 6/11 | NM_032968.5 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00743 AC: 818AN: 110111Hom.: 5 Cov.: 20 AF XY: 0.00674 AC XY: 218AN XY: 32343
GnomAD3 genomes
AF:
AC:
818
AN:
110111
Hom.:
Cov.:
20
AF XY:
AC XY:
218
AN XY:
32343
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00232 AC: 426AN: 183279Hom.: 6 AF XY: 0.00177 AC XY: 120AN XY: 67847
GnomAD3 exomes
AF:
AC:
426
AN:
183279
Hom.:
AF XY:
AC XY:
120
AN XY:
67847
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00112 AC: 1231AN: 1098089Hom.: 9 Cov.: 31 AF XY: 0.000979 AC XY: 356AN XY: 363565
GnomAD4 exome
AF:
AC:
1231
AN:
1098089
Hom.:
Cov.:
31
AF XY:
AC XY:
356
AN XY:
363565
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00744 AC: 820AN: 110167Hom.: 5 Cov.: 20 AF XY: 0.00679 AC XY: 220AN XY: 32409
GnomAD4 genome
AF:
AC:
820
AN:
110167
Hom.:
Cov.:
20
AF XY:
AC XY:
220
AN XY:
32409
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at